0,714  0,006  5 Hydroxytryptamine release stimulant
0,693  0,004  CYP2D6 inhibitor
0,651  0,005  CYP2C19 inhibitor
0,665  0,022  Antineoplastic (lung cancer)
0,655  0,029  Caspase 9 stimulant
0,635  0,014  Respiratory analeptic
0,594  0,017  Antidepressant
0,587  0,014  Spasmolytic
0,578  0,020  Mood disorders treatment
0,571  0,023  Antiparkinsonian
0,593  0,051  Apoptosis agonist
0,566  0,041  Antineoplastic (breast cancer)
0,527  0,004  Neurotrophic factor enhancer
0,535  0,017  Hepatic disorders treatment
0,531  0,020  Antineoplastic (melanoma)
0,532  0,027  Prostate cancer treatment
0,497  0,015  Cardiodepressant
0,490  0,022  Caspase 3 stimulant
0,472  0,007  Antiparkinsonian, rigidity relieving
0,477  0,012  Sigma receptor agonist
0,474  0,016  CYP3A4 inhibitor
0,499  0,044  Transcription factor NF kappa B inhibitor
0,481  0,044  CYP3A4 substrate
0,434  0,005  Alpha 2 adrenoreceptor antagonist
0,455  0,028  Analeptic
0,444  0,028  Antineoplastic (glioma)
0,427  0,012  Muscle relaxant
0,455  0,043  Antineoplastic (colorectal cancer)
0,450  0,041  Antineoplastic (colon cancer)
0,418  0,025  Antineoplastic (glioblastoma multiforme)
0,419  0,029  Antineoplastic (multiple myeloma)
0,391  0,010  Skeletal muscle relaxant
0,426  0,056  Antileukemic
0,366  0,009  Acetylcholine antagonist
0,399  0,044  Antineoplastic (ovarian cancer)
0,363  0,009  Cholinergic antagonist
0,368  0,017  Hepatoprotectant
0,416  0,068  Histamine release inhibitor
0,377  0,034  DNA damaging
0,369  0,033  Antineoplastic (lymphoma)
0,363  0,032  Antineoplastic (renal cancer)
0,371  0,051  CYP2D6 substrate
0,335  0,015  Cholinergic
0,366  0,047  Antineoplastic (brain cancer)
0,336  0,017  Antineoplastic (squamous cell carcinoma)
0,363  0,048  Antineoplastic (pancreatic cancer)
0,360  0,051  Vasodilator, coronary
0,377  0,071  CYP2C9 substrate
0,339  0,038  Urologic disorders treatment
0,354  0,053  Antiischemic
0,343  0,044  Sodium/bile acid cotransporter inhibitor
0,401  0,104  Antineoplastic (solid tumors)
0,310  0,017  Topoisomerase II inhibitor
0,337  0,049  Hypoxia-inducible factor 1 alpha inhibitor
0,297  0,011  Topoisomerase I inhibitor
0,283  0,003  Antineoplastic alkaloid
0,351  0,073  Vasodilator, peripheral
0,335  0,059  NOS3 expression inhibitor
0,347  0,079  Stroke treatment
0,324  0,059  CYP1A2 substrate
0,351  0,086  Immunosuppressant
0,270  0,017  Adenylate cyclase inhibitor
0,282  0,030  Urinary incontinence treatment
0,289  0,037  Abortion inducer
0,273  0,023  Antiischemic, cerebral
0,295  0,045  DNA synthesis inhibitor
0,273  0,027  Lipocortins synthesis antagonist
0,275  0,030  Male reproductive disfunction treatment
0,303  0,066  Radioprotector
0,289  0,055  Cytostatic
0,250  0,017  Antiadrenergic
0,246  0,017  Adrenaline antagonist
0,287  0,062  Antineoplastic (non-small cell lung cancer)
0,249  0,025  Acetylcholine M1 receptor antagonist
0,240  0,016  Acetylcholine muscarinic antagonist
0,237  0,017  Antitussive
0,238  0,019  Uterine stimulant
0,270  0,053  Antimitotic
0,268  0,052  Psychostimulant
0,226  0,011  Alpha 2a adrenoreceptor antagonist
0,250  0,042  UGT2B7 substrate
0,231  0,025  Acetylcholinesterase inhibitor
0,322  0,116  15-Lipoxygenase inhibitor
0,274  0,069  Antihypercholesterolemic
0,232  0,030  LDLR expression enhancer
0,252  0,051  Nitric oxide antagonist
0,230  0,030  Erectile dysfunction treatment
0,222  0,024  Alpha adrenoreceptor antagonist
0,213  0,021  Alpha 2b adrenoreceptor antagonist
0,259  0,068  Antineoplastic (liver cancer)
0,223  0,033  Lipid peroxidase inhibitor
0,276  0,088  Anxiolytic
0,204  0,017  Alpha 2c adrenoreceptor antagonist
0,189  0,007  Dopamine uptake inhibitor
0,197  0,015  Adenylate cyclase stimulant
0,252  0,072  NOS2 expression inhibitor
0,249  0,073  Acute neurologic disorders treatment
0,304  0,132  Antibacterial
0,200  0,028  Antiviral (Hepatitis B)
0,181  0,010  CDC-like kinase 3 inhibitor
0,210  0,041  Antineoplastic (carcinoma)
0,210  0,042  Liver fibrosis treatment
0,216  0,055  P-glycoprotein inhibitor
0,272  0,111  Antineoplastic (small cell lung cancer)
0,170  0,013  Dopamine agonist
0,182  0,027  Antismoking
0,198  0,045  Antiviral (Influenza A)
0,240  0,089  Antioxidant
0,164  0,013  Acetylcholine M3 receptor agonist
0,214  0,066  Antiviral (Influenza)
0,210  0,063  Chemopreventive
0,190  0,045  Attention deficit/hyperactivity disorder treatment
0,158  0,014  Dopamine D1 antagonist
0,239  0,099  CYP2C19 substrate
0,205  0,068  UDP-glucuronosyltransferase substrate
0,238  0,101  Immunostimulant
0,144  0,009  Nicotinic alpha4beta2 receptor antagonist
0,187  0,053  Prostate disorders treatment
0,182  0,049  UGT2B9 substrate
0,233  0,103  UGT2B4 substrate
0,298  0,169  Alzheimer's disease treatment
0,170  0,042  Bipolar disorder treatment
0,160  0,038  DNA intercalator
0,203  0,082  Antineoplastic enhancer
0,245  0,125  Interleukin 2 agonist
0,195  0,075  UGT1A1 substrate
0,172  0,053  CDC-like kinase 1 inhibitor
0,214  0,097  Myocardial infarction treatment
0,171  0,056  Carcinogenic, group 1
0,223  0,107  Antipsychotic
0,125  0,009  Alpha 2 adrenoreceptor agonist
0,217  0,105  Proliferative diseases treatment
0,137  0,024  Acetylcholine nicotinic antagonist
0,167  0,054  Genotoxic
0,162  0,050  Antifungal enhancer
0,124  0,014  Acetylcholine M3 receptor antagonist
0,128  0,019  5 Hydroxytryptamine uptake inhibitor
0,173  0,066  Thrombolytic
0,233  0,126  Bone diseases treatment
0,135  0,028  Dopamine antagonist
0,143  0,038  Alcohol dehydrogenase substrate
0,217  0,112  Antiosteoporotic
0,262  0,156  TNF expression inhibitor
0,203  0,098  Antineoplastic (cervical cancer)
0,202  0,097  Antineoplastic (lymphocytic leukemia)
0,123  0,019  Antiprotozoal activity enhancer
0,172  0,070  Prostatic (benign) hyperplasia treatment
0,136  0,037  Antiemetic
0,133  0,035  Estrogen antagonist
0,124  0,027  Dopamine D2 antagonist
0,246  0,150  Cognition disorders treatment
0,140  0,044  Microtubule formation inhibitor
0,162  0,067  Melanin inhibitor
0,207  0,112  Cardiotonic
0,119  0,025  Restless leg syndrome treatment
0,175  0,082  Antiviral (Hepatitis)
0,118  0,026  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,232  0,141  Antithrombotic
0,150  0,060  MAP3K9 inhibitor
0,176  0,085  Sedative
0,120  0,030  Topoisomerase II alpha inhibitor
0,226  0,136  AR expression inhibitor
0,169  0,079  Antineoplastic (bone cancer)
0,301  0,214  Antiinflammatory
0,091  0,006  Prolactin release inhibitor
0,194  0,109  Vasodilator
0,102  0,018  Adrenaline uptake inhibitor
0,139  0,054  5 Hydroxytryptamine antagonist
0,089  0,005  Dopamine D5 agonist
0,093  0,009  Nicotinic alpha3beta2 receptor antagonist
0,175  0,092  Antiarrhythmic
0,107  0,027  Phosphodiesterase XI inhibitor
0,107  0,027  Phosphodiesterase 11A inhibitor
0,207  0,126  Chemoprotective
0,088  0,009  Alpha-mannosidase inhibitor
0,160  0,081  Mutagenic
0,171  0,092  Cytotoxic
0,160  0,083  UGT2B10 substrate
0,133  0,056  Alkylator
0,112  0,036  SULT1E1 substrate
0,147  0,071  Protein kinase stimulant
0,222  0,147  Antihypertensive
0,083  0,007  Adenylate cyclase 1 inhibitor
0,090  0,014  Nitric oxide donor
0,113  0,041  Estrogen receptor beta antagonist
0,179  0,107  5 Hydroxytryptamine 3E antagonist
0,105  0,034  ATPase (Vacuolar H+) inhibitor
0,081  0,010  Kinesin-like protein 1 inhibitor
0,081  0,010  Kinesin antagonist
0,096  0,026  Neuronal nicotinic receptor antagonist
0,108  0,043  5 Hydroxytryptamine 2A antagonist
0,078  0,013  Dopamine D5 antagonist
0,078  0,014  Acetylcholine M2 receptor agonist
0,072  0,011  Mannosidase inhibitor
0,161  0,103  Anesthetic general
0,129  0,072  Tubulin antagonist
0,063  0,006  Phenylethanolamine N methyltransferase inhibitor
0,116  0,062  5 Hydroxytryptamine 2 antagonist
0,124  0,072  Papain-like protease (SARS coronavirus) inhibitor
0,107  0,056  Butyrylcholinesterase inhibitor
0,078  0,027  SULT2A1 substrate
0,152  0,102  Phospholipase C inhibitor
0,164  0,114  Teratogen
0,085  0,035  Alpha adrenoreceptor agonist
0,100  0,051  Phosphodiesterase 6D inhibitor
0,063  0,015  Factor III inhibitor
0,071  0,024  Alpha tubulin antagonist
0,082  0,037  Antitreponemal
0,169  0,124  Antiprotozoal (Leishmania)
0,080  0,037  Premenstrual syndrome treatment
0,047  0,005  Dopamine D1 agonist
0,088  0,046  Glycine receptor antagonist
0,102  0,060  Anabolic
0,074  0,033  5 Hydroxytryptamine 2A agonist
0,057  0,016  Neurokinin 1 antagonist
0,061  0,020  5 Hydroxytryptamine 2C agonist
0,064  0,023  Neurokinin antagonist
0,064  0,023  5 Hydroxytryptamine 2 agonist
0,096  0,057  Alpha 2d adrenoreceptor antagonist
0,122  0,083  Contraceptive
0,074  0,036  Dopamine D3 antagonist
0,115  0,077  Antiviral (Influenza B)
0,060  0,022  Nicotinic receptor alpha4 subunit antagonist
0,082  0,045  Acetylcholine M4 receptor antagonist
0,135  0,098  MAP kinase kinase 4 inhibitor
0,117  0,080  Cyclooxygenase 3 inhibitor
0,064  0,028  Lipocortins synthesis agonist
0,164  0,129  Free radical scavenger
0,081  0,046  Estrogen receptor alpha antagonist
0,132  0,099  UGT1A3 substrate
0,142  0,109  Sensitization
0,183  0,150  5 Hydroxytryptamine 1E antagonist
0,088  0,055  Sodium/hydrogen exchanger 5 inhibitor
0,039  0,007  Endothelin B receptor antagonist
0,063  0,031  Postmenopausal disorders treatment
0,138  0,106  Cystic fibrosis treatment
0,151  0,119  Embryotoxic
0,041  0,012  Endothelin receptor antagonist
0,067  0,039  Acetylcholine M2 receptor antagonist
0,157  0,129  Pneumotoxic
0,172  0,144  Peptidyltransferase inhibitor
0,092  0,064  Prolactin inhibitor
0,121  0,093  Antiparkinsonian, tremor relieving
0,200  0,173  CTGF expression inhibitor
0,148  0,122  Phobic disorders treatment
0,090  0,064  Antineoplastic, alkylator
0,202  0,177  Apoptosis antagonist
0,060  0,037  Ryanodine receptor antagonist
0,062  0,039  Acetylcholine M5 receptor antagonist
0,052  0,031  Dopamine transporter inhibitor
0,083  0,063  Transcription factor NF kappa B stimulant
0,082  0,063  Acetylcholine agonist
0,028  0,011  Endothelin A receptor antagonist
0,087  0,071  ABCA1 expression enhancer
0,184  0,169  12-Lipoxygenase inhibitor
0,090  0,076  UGT2B11 substrate
0,128  0,115  Pulmonary hypertension treatment
0,068  0,054  Phosphodiesterase V inhibitor
0,043  0,031  Nicotinic receptor alpha3 subunit antagonist
0,043  0,032  Dopamine D2 agonist
0,099  0,088  Activin receptor-like kinase 4 inhibitor
0,092  0,083  UGT2B1 substrate
0,063  0,054  Female sexual dysfunction treatment
0,177  0,170  Antineoplastic (sarcoma)
0,201  0,194  Antiprotozoal (Plasmodium)
0,129  0,125  Ca2+-transporting ATPase inhibitor
0,018  0,015  Vesicular acetylcholine transporter inhibitor
0,044  0,042  Phosphodiesterase 6C inhibitor
0,212  0,211  CYP2C9 inhibitor
0,093  0,092  DOPA decarboxylase inhibitor

